Compare EVMN & SERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVMN | SERV |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 724.7M |
| IPO Year | 2025 | N/A |
| Metric | EVMN | SERV |
|---|---|---|
| Price | $16.50 | $14.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $38.60 | $18.80 |
| AVG Volume (30 Days) | 325.9K | ★ 7.7M |
| Earning Date | 02-07-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,000,000.00 | $1,944,483.00 |
| Revenue This Year | $89.43 | $43.28 |
| Revenue Next Year | N/A | $893.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 160.00 | 15.76 |
| 52 Week Low | $13.89 | $4.66 |
| 52 Week High | $24.03 | $23.10 |
| Indicator | EVMN | SERV |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 64.42 |
| Support Level | N/A | $13.56 |
| Resistance Level | N/A | $16.08 |
| Average True Range (ATR) | 0.00 | 1.00 |
| MACD | 0.00 | 0.29 |
| Stochastic Oscillator | 0.00 | 79.56 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.